Veracyte to release Q2 2026 financial results on July 30
Veracyte will release its Q2 2026 financial results on July 30, 2026, followed by a conference call at 4:30 p.m. ET. The webcast will be available live on the company's website, with a replay accessible afterward.
*this image is generated using AI for illustrative purposes only.
Veracyte, Inc. will release its financial results for the second quarter of 2026 after the market closes on Thursday, July 30, 2026. The company, a global diagnostics firm focused on cancer care, scheduled the announcement to provide investors with an update on its performance. Management will host a conference call and webcast at 4:30 p.m. Eastern Time on the same day to discuss the financial results and offer a general business update.
The conference call will be webcast live from the company’s website. Investors can access the live broadcast via the provided link. A replay of the webcast will be available following the conclusion of the live event and will be accessible on the company’s investor relations website.
Conference Call Details
| Event | Date | Time |
|---|---|---|
| Financial Results Release | July 30, 2026 | After market close |
| Conference Call & Webcast | July 30, 2026 | 4:30 p.m. ET |
Veracyte’s portfolio includes molecular tests designed to assess tumor biology and assist clinicians in cancer care decisions. The company utilizes a diagnostics platform combining genomic data, bioinformatics, and AI to support its product pipeline.
What key performance indicators will investors be focusing on during the Q2 2026 earnings release?
How might Veracyte's AI-driven diagnostics platform influence its competitive position in the cancer care market by late 2026?
What potential market reactions could follow the announcement of Veracyte's Q2 financial results?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
